EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during Ramadan

Mohammed E Al-Sofiani, Goran Petrovski, Abdulrahman Al Shaikh, Abdullah Alguwaihes, Mohammad Al Harbi, Dabia Al Mohannadi, Alero Adjene, Abdulmoeen Alagha, Sareea Al Remeithi, Naji Alamuddin, Arcelia Arrieta, Javier Castañeda und 3 weitere

Diabetes, Obesity and Metabolism · 2024-03 · 26 (3) · 937-949

DOI: 10.1111/dom.15389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 27.12.2023. Verfasst von Mohammed E Al-Sofiani und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Hypoglycemia. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medtronic International Trading Sàrl.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To report on the effectiveness and safety of the MiniMed 780G automated insulin delivery system in real‐world users during the month of Ramadan. Materials and Methods CareLink Personal data were extracted from MiniMed 780G system users from the Gulf region. Users were included if they had ≥10 days of sensor glucose data during the month of Ramadan 2022 as well as in the month before and after. For the main analysis, continuous glucose monitoring endpoints were aggregated per month and were reported by time of day (daytime: 05.31‐18.00 h, and night‐time). Additional analyses were performed to study the pace at which the algorithm adapts.

Results

Glycaemic control was well kept in the 449 included users (mean sensor glucose = 152.6 ± 18.7 mg/dl, glucose management indicator = 7.0 ± 0.4%, time in range = 70.7 ± 11.0%, time below 70 mg/dl = 2.3 ± 2.3%). Albeit some metrics differed from the month before ( p < .0001 for all), absolute differences were very small and considered clinically irrelevant. During Ramadan, there was no increased risk of hypoglycaemia during daytime (time below 70 mg/dl = 2.3 ± 2.4%), time in range was highest during daytime (80.0 ± 10.7%, night: 60.4 ± 15.3%), while time above 180 mg/dl was highest during night‐time (37.3 ± 16.3%, day: 17.7 ± 10.7%). The algorithm adapted immediately upon lifestyle change.

Conclusion

The MiniMed 780G automated insulin delivery system is effective, safe and fast in adapting to the substantial changes that occur in the lifestyle of people with type 1 diabetes during Ramadan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1HypoglycemiaHumansInsulinBlood GlucoseBlood Glucose Self-MonitoringInsulin, Regular, HumanInsulin Infusion SystemsHypoglycemic Agents

Stichwörter der Autor:innen

continuous glucose monitoring (CGM)insulin therapyreal-world evidencetype 1 diabetes

Substanzen

InsulinBlood GlucoseInsulin, Regular, HumanHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University, Baltimore, Maryland, USA.
  • Division of Endocrinology, Department of Pediatric Medicine, Sidra Medicine, Doha, Qatar.
  • College of Medicine, Weill Cornell Medicine, Doha, Qatar.
  • Internal Medicine and Endocrinology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
  • Diabetes Center, Dallah Hospital, Riyadh, Saudi Arabia.

ORCID-Profile: Tim van den Heuvel

Förderung

  • Medtronic International Trading Sàrl

Zitieren

APA

Al-Sofiani, M. E., Petrovski, G., Al Shaikh, A., Alguwaihes, A., Al Harbi, M., Al Mohannadi, D., Adjene, A., Alagha, A., Al Remeithi, S., Alamuddin, N., Arrieta, A., Castañeda, J., Chaar, W., van den Heuvel, T., & Cohen, O. (2024). The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during Ramadan. Diabetes, Obesity and Metabolism, 26(3), 937-949. https://doi.org/10.1111/dom.15389

Vancouver

Al-Sofiani ME, Petrovski G, Al Shaikh A, Alguwaihes A, Al Harbi M, Al Mohannadi D, et al. The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during Ramadan. Diabetes, Obesity and Metabolism. 2024;26(3):937-949. doi:10.1111/dom.15389

BibTeX
@article{AlSofiani2024,
  author = {Al-Sofiani, Mohammed E and Petrovski, Goran and Al Shaikh, Abdulrahman and Alguwaihes, Abdullah and Al Harbi, Mohammad and Al Mohannadi, Dabia and Adjene, Alero and Alagha, Abdulmoeen and Al Remeithi, Sareea and Alamuddin, Naji and Arrieta, Arcelia and Castañeda, Javier and Chaar, Wael and van den Heuvel, Tim and Cohen, Ohad},
  title = {The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during Ramadan},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  volume = {26},
  number = {3},
  pages = {937--949},
  doi = {10.1111/dom.15389}
}
Kostenlos starten →